SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-240937
Filing Date
2010-10-29
Accepted
2010-10-29 12:46:13
Documents
10
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 913730
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 7869
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 7854
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 3244
  Complete submission text file 0001193125-10-240937.txt   4187757

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bmrn-20100930.xml EX-101.INS 728643
6 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20100930.xsd EX-101.SCH 17871
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20100930_cal.xml EX-101.CAL 45769
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20100930_def.xml EX-101.DEF 103017
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20100930_lab.xml EX-101.LAB 102575
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20100930_pre.xml EX-101.PRE 113350
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 101150705
SIC: 2834 Pharmaceutical Preparations